Masked Hypertension: Clinical Trials

4 trials for Masked Hypertension, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 2, Unknown 2

Follow Masked Hypertension: new trials by email Literature Review of Masked Hypertension trials Research Report on Masked Hypertension

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Antihypertensive Treatment in Masked Hypertension
Allisartan Isoproxil, Placebo - Masked Hypertension
Phase 4CompletedYan Li3202017-02-142025-01-06
Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes
"Liraglutide" and "Mitiglinide", "Metformin" and "Mitiglinide", "Mitiglinide" - Type 2 Diabetes, Overweight
Phase 4UnknownThird Affiliated Hospital of Third Military Medical University902015-05-012015-07-21
The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension
Gastrodia and Uncaria Drink - Masked Hypertension
Phase 4UnknownShanghai Institute of Hypertension4002014-03-012014-06-06
Cardiovascular Impact of Obstructive Sleep Apnea Treatment in Normotensive Patients
CPAP - Obstructive Sleep Apnea
Phase 4CompletedUniversity of Sao Paulo362008-08-012010-10-28

Narrower conditions

Diabetes Mellitus, Type 2 (1)  ·  Hypertrophy, Left Ventricular (1)  ·  Obesity (1)  ·  Overweight (1)  ·  Prehypertension (1)  ·  Sleep Apnea, Obstructive (1)

Broader conditions

Cardiovascular Diseases (4)  ·  Hypertension (4)  ·  Vascular Diseases (4)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Apnea (1)  ·  Body Weight (1)  ·  Cardiomegaly (1)  ·  Diabetes Mellitus (1)  ·  Dyssomnias (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Heart Diseases (1)  ·  Hypertrophy (1)  ·  Metabolic Diseases (1)  ·  Nervous System Diseases (1)

Interventions

Liraglutide (1)  ·  Metformin (1)  ·  allisartan isoproxil (1)  ·  gastrodin (1)  ·  mitiglinide (1)

Sponsors

Shanghai Institute of Hypertension (1)  ·  Third Affiliated Hospital of Third Military Medical University (1)  ·  University of Sao Paulo (1)  ·  Yan Li (1)

Countries

China (2)  ·  Brazil (1)

Top investigators

Zhiming Zhu, MD, PHD (1)

Results publications

PMID 26150543, PMID 33019798, PMID 39091669